Another fusion of interest, FSIP1::RP11-624L4.1, is present in 240 (22%) of breast tumors analyzed and in 16 normal breast tissues samples, where it is expressed at significantly lower levels in normal tissues (Figure S10). Here, FSIP1 is linked to breast neoplasm.